Publisher: GlobalData
Category: Prescription Drugs

Prescription Drugs market research reports by GlobalData

(51 reports matching your criteria)
    • Parkinson's Disease Seven-Market Drug Forecast and Market Analysis

      Parkinson's Disease Seven-Market Drug Forecast and Market Analysis Summary This report covers the 7 major markets and provides an Excel-based forecast model for the Parkinson's Disease market through 2033. GlobalData estimates that drug sales for PD in 2023 were approximately $3.4 billion across the ... Read More

    • Obesity: 68-Market Analysis and Sales Forecast

      Obesity: 68-Market Analysis and Sales Forecast Summary This report covers the 68 geographical markets and provides an Excel-based forecast model for the obesity market through 2031. Across the 68 markets, sales in the obesity market were $12.3 billion in 2021, growing to $206.5 billion in 2031. The ... Read More

    • Obesity in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2031

      Obesity in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2031 Summary This report covers the 7MM (US, France, Germany, Italy, Spain, UK, Japan) and provides an Excel-based forecast model for the obesity market through 2031. GlobalData estimate ... Read More

    • Parkinson's Disease in 68 Markets - Disease Overview, Product Profiles, Patient Flow, Competitive Assessment and Sales Forecast to 2033

      Parkinson's Disease in 68 Markets - Disease Overview, Product Profiles, Patient Flow, Competitive Assessment and Sales Forecast to 2033 Summary This report covers the 68 geographical markets and provides an Excel-based forecast model for the Parkinson's Disease market through 2033. GlobalData estima ... Read More

    • Hyperlipidemia: Competitive Landscape

      Hyperlipidemia: Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Hyperlipidemia therapeutics. GlobalData epidemiologists estimate 128,720,003 total prevalent cases of high low-density lipoprotein C (LDL-C) with high triglyc ... Read More

    • Hepatitis C Therapeutics: Competitive Landscape

      Hepatitis C Therapeutics: Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Hepatitis C Therapeutics . GlobalData epidemiologists estimate that there will be 25.16 million diagnosed prevalent cases of Hepatitis C (HCV) infec ... Read More

    • Acute-on-Chronic Liver Failure: Competitive Landscape

      Acute-on-Chronic Liver Failure: Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Acute-on-Chronic Liver Failure therapeutics. GlobalData epidemiologists estimated that there are 71,713 diagnosed incident cases of acute-on-c ... Read More

    • Rett Syndrome: Competitive Landscape

      Rett Syndrome: Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Rett Syndrome therapeutics. In the 16 countries covered in GlobalData’s epidemiology forecast for Rett syndrome (RS), there are projected to be 97,327 diagnose ... Read More

    • Contract Pharmaceutical Dose Manufacturing Industry: Composition, Size, Market Share and Outlook - 2024 Edition

      Contract Pharmaceutical Dose Manufacturing Industry: Composition, Size, Market Share and Outlook - 2024 Edition Summary This expert trend report is a comprehensive look at the pharmaceutical finished dose contract manufacturing landscape in 2024, including analysis of dose CMO M&A activity, market s ... Read More

    • Strategic Intelligence: Pharma M&A Deals Q3 2024 - Top Themes

      Strategic Intelligence: Pharma M&A Deals Q3 2024 - Top Themes Summary This report analyzes the disruptive themes that have driven M&A activity in Q3 2024 in the pharma Sector. The global pharma sector in Q3 2024 witnessed deals worth $35 billion, a decline of 3% compared to Q3 2023. In terms of deal ... Read More

    • Neurofibromatoses: Competitive Landscape

      Neurofibromatoses: Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Nurofibromatoses therapeutics. In 2024, more than 986,000 diagnosed prevalent cases of Nurofibromatoses are anticipated in the 16 countries covered in Glob ... Read More

    • Migraine: 68-Market Analysis and Sales Forecast

      Migraine: 68-Market Analysis and Sales Forecast Summary GlobalData estimates that the value of the migraine market in the 7MM in 2023 was $9.2 billion. This market is defined as sales of acute and preventative treatments including widely used triptans and ergot alkaloids used in abortive treatment a ... Read More

    • Migraine: Seven-Market Drug Forecast and Market Analysis

      Migraine: Seven-Market Drug Forecast and Market Analysis Summary This report covers the 7MM (US, France, Germany, Italy, Spain, UK, Japan) and provides an Excel-based forecast model for the Migraine market through 2033. GlobalData estimates that the value of the migraine market in the 7MM in 2023 wa ... Read More

    • Chronic Urticaria: Competitive Landscape

      Chronic Urticaria: Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in chronic urticaria therapeutics. In 2024, more than 60 million diagnosed prevalent cases of CU are anticipated in the 16 countries covered in GlobalData’s e ... Read More

    • Clinical Trials: Psychedelic Therapeutics

      Clinical Trials: Psychedelic Therapeutics Summary This report provides a review of global psychedelic therapeutic clinical trials derived from the GlobalData’s Clinical Trials Database. The aim of this report is to identify key analyses and segmentations of these trials. As the number of psychedelic ... Read More

    • Substance (Drug) Abuse - Global Clinical Trials Review, 2024

      Substance (Drug) Abuse - Global Clinical Trials Review, 2024 Substance (Drug) Abuse - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Substance (Drug) Abuse - Global Clinical Trials Review, 2024"" provides an overview of Substance (Drug) Abuse Clinical trials scenari ... Read More

    • Osteoporosis: Seven-Market Drug Forecast and Market Analysis

      Osteoporosis: Seven-Market Drug Forecast and Market Analysis Summary This report covers the 7MM (US, France, Germany, Italy, Spain, UK, Japan) and provides an Excel-based forecast model for the Osteoporosis market through 2033. Osteoporosis is defined as a systemic skeletal disease characterized by ... Read More

    • Attention Deficit Hyperactivity Disorder (ADHD): Opportunity Assessment and Forecast 2022-2032

      Attention Deficit Hyperactivity Disorder (ADHD): Opportunity Assessment and Forecast 2022-2032 Summary This report covers the 7MM (US, France, Germany, Italy, Spain, UK, Japan) and provides an Excel-based forecast model for the Attention Deficit Hyperactivity Disorder (ADHD) market through 2032. The ... Read More

    • New Prescription - Generative AI meets Healthcare (Vol. 2)

      New Prescription - Generative AI meets Healthcare (Vol. 2) Summary GlobalData's latest Innovation Radar report New Prescription: Generative AI Meets Healthcare (Vol. 2), expands upon its predecessor and digs further into the transformative capabilities of generative AI within the pharmaceutical and ... Read More

    • Reddit's Analysis on the Efficacy of Leading Weight Loss Drugs

      Reddit's Analysis on the Efficacy of Leading Weight Loss Drugs Summary This comprehensive conversation analysis report delves into the most popular weight loss drugs on Reddit in the last six months (October 1st, 2023, to March 31st, 2024), offering a nuanced understanding of their prominence and po ... Read More

    • Psychedelics Therapeutics Development and Trends, 2024

      Psychedelics Therapeutics Development and Trends, 2024 Summary This report provides a summary of the current and future state of the psychedelic therapeutic sector, offering a high-level analysis of key trends and developments within the industry, including regulatory, clinical, and market dynamics. ... Read More

    • Pharma M&A Deals 2023 - Top Themes - Thematic Research

      Pharma M&A Deals 2023 - Top Themes - Thematic Research Summary This report analyzes the disruptive themes that have driven M&A activity in 2023 in the Pharma Sector The global pharma sector in 2023 witnessed deals worth $233 billion, a growth of 81% compared to 2022. In terms of deal volume also, th ... Read More

    • France Reversible Contraceptive Procedures Count by Segments and Forecast to 2030

      France Reversible Contraceptive Procedures Count by Segments and Forecast to 2030 Summary GlobalData’s “France Reversible Contraceptive Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the France Reversible Contraceptive Procedures. The databook report ... Read More

    • United States (US) Reversible Contraceptive Procedures Count by Segments and Forecast to 2030

      United States (US) Reversible Contraceptive Procedures Count by Segments and Forecast to 2030 Summary GlobalData’s “United States Reversible Contraceptive Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the United States Reversible Contraceptive Proced ... Read More

    • United Kingdom (UK) Reversible Contraceptive Procedures Count by Segments and Forecast to 2030

      United Kingdom (UK) Reversible Contraceptive Procedures Count by Segments and Forecast to 2030 Summary GlobalData’s “United Kingdom Reversible Contraceptive Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the United Kingdom Reversible Contraceptive Pro ... Read More

< prev 1 2 3

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings